Analysis of the cerebrospinal fluid can detect whether a person has Alzheimer's disease before symptoms appear. Researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have ...
CNSide CSF Molecular Profile provides comprehensive DNA and RNA profiling of CNS disease biology from cerebrospinal fluid. The tests analyze more than 300 cancer-related genes in cell-free DNA and ...
Blood can reveal neurological injury, cerebrospinal fluid can provide biological context, and multiomic approaches can ...
The newly FDA-cleared tests can run on any of Roche’s Cobas immunoassay analyzers. Both are cerebrospinal fluid assays: They analyze CSF samples to measure the concentration of beta-amyloid and tau ...
Newswise — Researchers with the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine and four other institutions have developed a molecular test to identify the presence ...
Blood tests for Alzheimer’s disease are now so accurate that a positive result, on its own, is reason enough for people who are suspected of having AD to start immunotherapy. So proffered Suzanne ...
HOUSTON, Oct. 06, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) (“Cerenome” or the “Company ”), today announced the commercial launch of ...
(MENAFN- GlobeNewsWire - Nasdaq) New DNA and RNA tests expand CNSide beyond leptomeningeal metastases to molecular profiling across CNS oncology HOUSTON, Oct. 06, 2026 (GLOBE NEWSWIRE) -- CNSide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results